Decentralized clinical trial (DCT) strategies can streamline a clinical study and reduce overall costs, but they come with unique challenges. PROMETRIKA has guided our clients through deployment of DCT strategies and monitoring their impact with the end result being well-run clinical studies.

When considering incorporating DCT strategies at the outset of a study, it is important to take into account what tools are best suited to the study’s objectives, phase, and investigational product/device, among other considerations. While launching a study with DCT incorporated from the start is ideal, we can also assist clients with implementing DCT strategies midstream, as this requires careful planning and coordination to make the transition to DCT as seamless as possible for all teams and vendors.

PROMETRIKA offers the services listed below aimed at customizing the approach to DCT for each client and study. We look forward to bringing this knowledge to bear for our prospective partners.

  • Generate DCT implementation strategy led by Clinical Operations with input from functional teams as needed.
  • Develop a transition plan if incorporating DCT after a study is underway. 
  • Ensure appropriate training on the use of DCT tools for site staff, monitors, and other team members
  • Monitor the performance of DCT strategies based on quality tolerance limits generated from a risk assessment performed by PROMETRIKA experts with input from the sponsor and relevant functional teams.